Vision loss and diabetic retinopathy prevalence and risk among a cohort of Indigenous and non-Indigenous Australians with type 2 diabetes receiving renal haemodialysis treatment: The retinopathy in people currently on renal dialysis (RiPCORD) study
Ocular complications among individuals with T2D and ESRF are disproportionately high, especially for Indigenous Australians, and beyond what can be accounted for by risk factor variation. Findings suggest a need to improve screening and preventative efforts within this high-risk population group.
Authors
- Tania Roulston
- Natasha J Howard (ORCID: https://orcid.org/0000-0002-8099-3107)
- Alex D. H. Brown (ORCID: https://orcid.org/0000-0003-2112-3918)
- Jamie E. Craig (ORCID: https://orcid.org/0000-0001-9955-9696)
- Stewart Lake (ORCID: https://orcid.org/0000-0003-0078-3319)
- Louise Maple‐Brown (ORCID: https://orcid.org/0000-0002-9067-2737)
- Jose J. Estevez (ORCID: https://orcid.org/0000-0003-2722-0700)
- Jonathan Gleadle
- Ebony Liu (ORCID: https://orcid.org/0000-0002-4542-9084)
- Chirag J. Patel (ORCID: https://orcid.org/0000-0002-8756-8525)
- Tim Henderson
Institutions
- Australian Centre for Plant Functional Genomics (AU)
- Flinders University (AU)
- Flinders Medical Centre (AU)
- Charles Darwin University (AU)
- Adelaide Institute for Sleep Health (AU)
- South Australian Health and Medical Research Institute (AU)
- Alice Springs Hospital (AU)
- Royal Darwin Hospital (AU)
Publication Details
- Journal
- Primary care diabetes
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1016/j.pcd.2024.08.005
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Diabetes Australia
- Medical Research Council
- National Health and Medical Research Council